Sunshine Biopharma Inc.
13F holders, Q2 2024 (June 30)11holders
$0.41avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Sunshine Biopharma Inc. in their 13F filings. The largest holders were Susquehanna International Group, LLP ($32K), XTX Topco Ltd ($18K) and HRT Financial LP ($18K).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781601
- Latest filing quarter
- Q2 2024
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $90K |
| Exits | 0 | $0 |
Ownership 11 holders
| Susquehanna International Group, LLP | 0.00% | New | 76,967 | $32K |
| XTX Topco Ltd | 0.00% | New | 44,008 | $18K |
| HRT Financial LP | 0.00% | New | 45,022 | $18K |
| Jane Street Group, LLC | 0.00% | New | 27,856 | $12K |
| Sabby Management, LLC | 0.12% | New | 20,000 | $8K |
| Qube Research & Technologies Ltd | 0.00% | New | 1,529 | $638 |
| Morgan Stanley | 0.00% | New | 1,000 | $418 |
| Bank of America Corp. | 0.00% | New | 100 | $42 |
| National Bank of Canada | 0.00% | New | 65 | $26 |
| Main Street Group, LTD | 0.00% | New | 3 | $1 |
| UBS Group AG | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.